Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hemagglutinin (HA) protein is a major surface glycoprotein of the influenza A virus, responsible for binding to host cell receptors and mediating viral entry. The H7 subtype refers to one of the 18 known HA subtypes in influenza A viruses. The H7 hemagglutinin is particularly relevant due to its association with avian influenza outbreaks and occasional zoonotic transmission to humans. It binds sialic acid-containing receptors on host cells and undergoes conformational changes to trigger membrane fusion.
Neutralizing antibodies block attachment and membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza A virus Hemagglutinin protein subtype H7.